Mental illness segregation and truncated autonomy within medical assistance in dying legislative frameworks in Colombia and Canada. [PDF]
Bastidas-Bilbao H +3 more
europepmc +1 more source
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +15 more
wiley +1 more source
Assessing and managing patients with borderline personality disorder requesting medical assistance in dying. [PDF]
Links PS, Aslam H, Brodeur J.
europepmc +1 more source
Bene Mori: The Right of the Patient to Die with Dignity [PDF]
Cavanagh, John R.
core +1 more source
Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL
ABSTRACT Objective Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact ...
Léa Aguilhon +5 more
wiley +1 more source
Advance Requests for Medical Assistance in Dying in the International Context: Some Legal Issues for the Canadian Case. [PDF]
Espericueta L.
europepmc +1 more source
A Review of Richard Coleson\u27s The Glucksberg and Quill Amicus Curiae Briefs: Verbatim Arguments Opposing Assisted Suicide [PDF]
Howard, Joseph
core +1 more source
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti +19 more
wiley +1 more source
Rural healthcare professionals' participation in Medical Assistance in Dying (MAiD): beyond a binary decision. [PDF]
Sedgwick M +2 more
europepmc +1 more source
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner +14 more
wiley +1 more source

